Repare Therapeutics (RPTX) Competitors $1.82 0.00 (0.00%) Closing price 10/8/2025 04:00 PM EasternExtended Trading$1.90 +0.08 (+4.34%) As of 10/8/2025 04:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock RPTX vs. CADL, SCPH, TKNO, SOPH, NMRA, ALLO, JBIO, TECX, ABEO, and GALTShould you be buying Repare Therapeutics stock or one of its competitors? The main competitors of Repare Therapeutics include Candel Therapeutics (CADL), scPharmaceuticals (SCPH), Alpha Teknova (TKNO), SOPHiA GENETICS (SOPH), Neumora Therapeutics (NMRA), Allogene Therapeutics (ALLO), Jade Biosciences (JBIO), Tectonic Therapeutic (TECX), Abeona Therapeutics (ABEO), and Galectin Therapeutics (GALT). These companies are all part of the "pharmaceutical products" industry. Repare Therapeutics vs. Its Competitors Candel Therapeutics scPharmaceuticals Alpha Teknova SOPHiA GENETICS Neumora Therapeutics Allogene Therapeutics Jade Biosciences Tectonic Therapeutic Abeona Therapeutics Galectin Therapeutics Candel Therapeutics (NASDAQ:CADL) and Repare Therapeutics (NASDAQ:RPTX) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, media sentiment, analyst recommendations, institutional ownership, risk, earnings, valuation and dividends. Do insiders & institutionals have more ownership in CADL or RPTX? 13.9% of Candel Therapeutics shares are held by institutional investors. Comparatively, 85.1% of Repare Therapeutics shares are held by institutional investors. 16.6% of Candel Therapeutics shares are held by insiders. Comparatively, 11.5% of Repare Therapeutics shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth. Is CADL or RPTX more profitable? Candel Therapeutics' return on equity of -41.00% beat Repare Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Candel TherapeuticsN/A -41.00% -26.81% Repare Therapeutics N/A -78.25%-66.85% Do analysts recommend CADL or RPTX? Candel Therapeutics currently has a consensus target price of $20.00, suggesting a potential upside of 217.46%. Repare Therapeutics has a consensus target price of $4.50, suggesting a potential upside of 147.25%. Given Candel Therapeutics' stronger consensus rating and higher possible upside, equities analysts plainly believe Candel Therapeutics is more favorable than Repare Therapeutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Candel Therapeutics 1 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 1 Strong Buy rating(s) 2.67Repare Therapeutics 1 Sell rating(s) 2 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.20 Which has better valuation & earnings, CADL or RPTX? Candel Therapeutics has higher earnings, but lower revenue than Repare Therapeutics. Candel Therapeutics is trading at a lower price-to-earnings ratio than Repare Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCandel TherapeuticsN/AN/A-$55.18M-$0.69-9.13Repare Therapeutics$53.48M1.46-$84.69M-$2.58-0.71 Which has more risk & volatility, CADL or RPTX? Candel Therapeutics has a beta of -0.94, indicating that its stock price is 194% less volatile than the S&P 500. Comparatively, Repare Therapeutics has a beta of 1.08, indicating that its stock price is 8% more volatile than the S&P 500. Does the media refer more to CADL or RPTX? In the previous week, Repare Therapeutics had 2 more articles in the media than Candel Therapeutics. MarketBeat recorded 4 mentions for Repare Therapeutics and 2 mentions for Candel Therapeutics. Candel Therapeutics' average media sentiment score of 0.95 beat Repare Therapeutics' score of 0.51 indicating that Candel Therapeutics is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Candel Therapeutics 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Repare Therapeutics 1 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummaryCandel Therapeutics beats Repare Therapeutics on 10 of the 15 factors compared between the two stocks. Get Repare Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for RPTX and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding RPTX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart RPTX vs. The Competition Export to ExcelMetricRepare TherapeuticsMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$78.19M$3.35B$6.09B$10.54BDividend YieldN/A2.28%5.69%4.71%P/E Ratio-0.7121.5785.4827.61Price / Sales1.46271.42535.60201.12Price / CashN/A47.1237.9261.55Price / Book0.5110.1412.976.76Net Income-$84.69M-$52.31M$3.30B$275.88M7 Day Performance-1.09%5.14%4.35%2.81%1 Month Performance5.20%14.68%9.50%9.24%1 Year Performance-45.02%30.98%84.38%35.42% Repare Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)RPTXRepare Therapeutics2.8005 of 5 stars$1.82flat$4.50+147.3%-47.2%$78.19M$53.48M-0.71180News CoverageAnalyst ForecastCADLCandel Therapeutics2.5923 of 5 stars$5.47-1.6%$20.00+265.6%+2.4%$305.22M$120K-7.9360Analyst ForecastSCPHscPharmaceuticals3.8098 of 5 stars$5.67flat$7.78+37.3%N/A$302.20M$49.97M-3.1330Analyst ForecastHigh Trading VolumeTKNOAlpha Teknova2.0963 of 5 stars$5.65+0.2%$10.00+77.0%+7.3%$301.83M$37.74M-13.45240News CoverageAnalyst ForecastSOPHSOPHiA GENETICS2.3734 of 5 stars$4.05-8.0%$8.00+97.5%+32.2%$297.35M$65.17M-9.20520News CoverageAnalyst ForecastHigh Trading VolumeNMRANeumora Therapeutics2.4203 of 5 stars$1.89+3.3%$7.14+277.9%-86.8%$296.36MN/A-1.20108Positive NewsAnalyst ForecastALLOAllogene Therapeutics2.7399 of 5 stars$1.38+3.8%$8.44+511.9%-46.4%$295.10M$20K-1.24310Analyst ForecastJBIOJade Biosciences2.8171 of 5 stars$9.14+3.2%$16.00+75.1%N/A$289.07MN/A-0.3020Analyst ForecastTECXTectonic Therapeutic2.7949 of 5 stars$15.20-0.3%$80.29+428.2%-51.9%$285.17MN/A-3.76120News CoverageAnalyst ForecastABEOAbeona Therapeutics4.3411 of 5 stars$5.34-1.3%$19.50+265.2%-15.2%$277.42M$400K7.6390News CoverageAnalyst ForecastGALTGalectin Therapeutics1.2931 of 5 stars$4.44+2.5%$6.00+35.1%+73.0%$277.38MN/A-6.949News CoverageAnalyst Forecast Related Companies and Tools Related Companies Candel Therapeutics Alternatives scPharmaceuticals Alternatives Alpha Teknova Alternatives SOPHiA GENETICS Alternatives Neumora Therapeutics Alternatives Allogene Therapeutics Alternatives Jade Biosciences Alternatives Tectonic Therapeutic Alternatives Abeona Therapeutics Alternatives Galectin Therapeutics Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:RPTX) was last updated on 10/9/2025 by MarketBeat.com Staff From Our PartnersMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredREVEALED: Something Big Happening Behind White House DoorsWhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | Sponsored2013 miner reveals his trading systemWhile everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredThe Tiny Stock Set to Soar with Musk's AI AmbitionsThe Tiny Stock Set to Soar with Musk's AI Ambitions While Musk builds one of the most ambitious AI empires ...Behind the Markets | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Repare Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Repare Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
